Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


PBAC in meds inquiry hot seat

Posted 11 June 2021 AM

The Zimmerman inquiry has announced another three days of public hearings with the chair of PBAC, Professor Andrew Wilson, scheduled to take the hot seat in a fortnight.

After hearing evidence from witnesses in three states and receiving 195 submissions - the finger of blame for Australia's poor track record in medicines approval has been pointed squarely and repeatedly at PBAC since the inquiry was announced last August.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Could access probe be for nothing?
Significant industry participation but what outcome?
Approvals Action
Injectable antibiotic ticked
Fresenius Kabi adds to Gram-positive options